Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has announced that its trading window will be closed for designated persons and their immediate relatives from January 1, 2026 until 48 hours after the announcement of unaudited financial results for the quarter and nine months ending December 31, 2025. This is a standard compliance step under SEBI's Insider Trading Regulations to prevent trading on unpublished price-sensitive information. The date of the board meeting to approve these Q3 results has not yet been disclosed and will be communicated later. The window restriction applies to company insiders who may have access to the financial results before public release.
This is a routine regulatory disclosure with no direct impact on share price. It signals that the company's Q3 FY26 earnings announcement is approaching, which investors should watch for as the next significant event.